18F-HER2 PET
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| 18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma. (NCT05983796) | First Affiliated Hospital of Zhejiang University | 2023-08-10 |
Track 18F-HER2 PET automatically
Every clearance here is in the API, with alerts when new ones post.